Influenza vaccines promote humoral and cellular immune responses: a randomized, double-blind, phase 3 trial.
Rodríguez-Guilarte L, Méndez C, Reyes A, Rios M, Román F, Moreno-Tapia D, Cabrera A, Rivera DB, Gutiérrez-Vera C, Palacios PA, Schilling A, Aljaro S, Bascur F, Rojas Á, Del Río C, Astudillo P, Perez CM, Perez L, Oyonarte M, Fernández Vásquez PE, Feijoo RM, Beltrán Campos D, Tovar De Sousa C, Castejón A, Grandón S, Villarroel M, Jara P, Twele L, Angélica Domínguez M, González-Aramundiz JV, Álvarez-Figueroa MJ, Yang W, Xin Q, Carreño LJ, Calvo M, Bueno SM, Peñaloza HF, González PA, Kalergis AM.
Rodríguez-Guilarte L, et al. Among authors: gonzalez pa.
Nat Commun. 2025 Dec 7;17(1):407. doi: 10.1038/s41467-025-67102-y.
Nat Commun. 2025.
PMID: 41354738
Free PMC article.
Clinical Trial.